News

Researchers report a new molecule that inhibits drug-resistant bacteria in lab experiments, as well as in mice with pneumonia and urinary tract infections, which could one day be used to treat challenging infections in humans.

A transposable element or "jumping" gene in mice has been shown to control the immune system in response to viral infection, promoting host survival.

How do a wide variety of bacteria — both pathogenic and commensal — survive antimicrobials released by the mammalian innate immune system?

An ongoing program that monitors wastewater for the presence of SARS-CoV-2 and has effectively predicted subsequent surges in COVID-19 cases in San Diego has been expanded to detect the presence of monkeypox.

Research reports for the first time a pathway that begins in the gut and ends with a potent pro-inflammatory toxin in brain cells contributing to the development of Alzheimer’s disease (AD).

According to a study, next-generation sequencing diagnostic systems enable clinicians to simultaneously sequence multiple strands of DNA found in patient samples and use that analysis to identify a single pathogen.

The tuberculosis (TB) vaccine, bacille Calmette-Guérin (BCG), is one of the most widely administered vaccines across the globe. Nearly 100 years old, it is the only vaccine ever administered to treat TB, which afflicts more than 10 million people each year.

A small molecule has been designed that can be used as a molecular tool to trigger immunogenic cell death, enabling researchers to better understand the effects of damage-associated molecular patterns in immunity.

Research shows that higher concentrations of microbe-carrying dust are landing at lower elevations, where people are more likely to be hiking.

A collaborative research team has synthesized a molecule that could be used as an alternative to the antibodies used in immunotherapy treatment for cancer. The study is published in the Journal for ImmunoTherapy of Cancer.